Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Reactogenicity and immunogenicity of GSK Biologicals' influenza vaccine GSK576389A in elderly adults (≥67 years) previously vaccinated with the same candidate vaccine. Fluarix™ will be used as reference.
Influenza Vaccine
110223
NCT00538473
Influenza
Phase 2
 
An annotated case report form is not available for this study. A blank case report form will be provided.
May 2013

Powered by ideaPoint, Inc.